-
公开(公告)号:US10071093B2
公开(公告)日:2018-09-11
申请号:US15634262
申请日:2017-06-27
申请人: VERSI GROUP, LLC
IPC分类号: A61K31/497 , A61K31/495 , A61K31/496 , A61K45/06 , C07D241/04 , A61K9/70
CPC分类号: A61K31/495 , A61K9/7023 , A61K31/496 , A61K45/06 , C07D241/04 , A61K2300/00
摘要: Compositions and methods for treatment of Parkinson's disease to reduce the negative side effects of the disease by administering a therapeutically effective diarylmethylpiperazine compound which exhibits delta opioid receptor agonist activity, and optionally, mu receptor antagonist activity.